| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +50.00% | -4.69% | +1.10% | -5.79% | -5.79% | — |
| 14d | 2 | +50.00% | -8.14% | -0.58% | -7.56% | -7.56% | — |
| 30d | 2 | +50.00% | +4.72% | -2.95% | +7.67% | +7.67% | — |
| 60d | 2 | +50.00% | +7.50% | +1.92% | +5.58% | +5.58% | — |
| 90d | 2 | +50.00% | +6.88% | +5.55% | +1.32% | +1.32% | — |
| 180d | 2 | +0.00% | -39.33% | +9.35% | -48.68% | -48.68% | — |
| 1y | 2 | +50.00% | -32.05% | +24.05% | -56.10% | -56.10% | — |
| 2y | 2 | +0.00% | -56.74% | +46.31% | -103.05% | -103.05% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,000,000 | — | — | 3,000,000 | Feb 3, 2026 | Feb 5, 2026 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,000,000 | — | — | 3,000,000 | Aug 26, 2025 | Aug 28, 2025 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 4,447 | — | — | 4,447 | Jul 15, 2024 | Jul 17, 2024 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 46,528 | — | — | 46,528 | Jul 15, 2024 | Jul 17, 2024 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 190,000 | — | — | 190,000 | Feb 21, 2024 | Feb 23, 2024 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASE Chief Executive Officer | 1,740 | $0.88 | $1.5K | 5,232,304 | Dec 7, 2023 | Dec 8, 2023 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 525,000 | — | — | 525,000 | Mar 14, 2023 | Mar 16, 2023 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 35,000 | — | — | 35,000 | Sep 13, 2022 | Sep 15, 2022 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 14,000 | $0.74 | $10.3K | 5,230,564 | Sep 7, 2022 | Sep 8, 2022 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 21,218 | — | — | 21,218 | Mar 16, 2022 | Mar 18, 2022 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 162,850 | — | — | 162,850 | Oct 22, 2021 | Oct 26, 2021 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 23,264 | — | — | 23,264 | Oct 22, 2021 | Oct 26, 2021 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 139,585 | — | — | 139,585 | Oct 22, 2021 | Oct 26, 2021 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 5,213,764 | — | — | 5,213,764 | Oct 22, 2021 | Oct 26, 2021 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 2,106,361 | — | — | 2,106,361 | Oct 22, 2021 | Oct 26, 2021 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 197,374 | — | — | 197,374 | Oct 22, 2021 | Oct 26, 2021 ↗ | View → |
| SABS SAB BIOTHERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 2,800 | $10.07 | $28.2K | 2,800 | Oct 7, 2021 | Oct 26, 2021 ↗ | View → |